The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
Last updated
Peptide Profile

Ketamine: Research, Dosing, and Where to Buy in 2026

A research-first profile for Ketamine (khole, Kholes), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

⚕️ US PRESCRIPTION REQUIRED. Ketamine is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Ketamine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for Ketamine, each linked to its source.

Key Facts
Pharmaceutical
  • Also indexed as khole, Kholes.
  • 0 aggregated dosing-protocol mentions from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Ketamine?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Ketamine Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

No transcript-derived dosing mentions in current source set.

Where to Buy Ketamine in 2026

No tracked vendor recommendations for Ketamine yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Ketamine. Each line links to the original source.

  • "A total of 363 trials were manually assessed from clinicaltrial.gov with the search term "Ketamine." The highest number of trials were found for the FDA-approved indications: anesthesia (~22%) and pain management (~28%) for ketamine and TRD for esketamine (~29%)." · Vekhova K et al, 2025 PubMed
  • "We conducted random-effects meta-analyses using pooled rate ratios (RRs) and Cohen's standardized mean differences (d) with their 95% confidence intervals (CI)." · Bahji A et al, 2022 PubMed
  • "We found 36 studies (2903 participants, 57% female, 45.1 +/- 7.0 years)." · Bahji A et al, 2022 PubMed
  • "Treatment with any form of ketamine was associated with improved response (RR=2.14; 95% CI, 1.72-2.66; I2=65%), remission (RR=1.64; 95% CI, 1.33-2.02; I2=39%), and depression severity (d=-0.63; 95% CI, -0.80 to -0.45; I2=78%) against placebo." · Bahji A et al, 2022 PubMed

Research and Studies

8 PubMed-indexed papers reference Ketamine. Top 8 shown.

Frequently Asked Questions

Is Ketamine FDA-approved?

Ketamine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

How much research has been published on Ketamine?

8 PubMed-indexed paper(s) reference Ketamine in our current research feed. See the Research and Studies section above for citations.